Interleukin-targeting biologics associated with lower infection rates in older psoriatic patients
Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...
FDA approves Tremfya for active Crohn's disease in adults
The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for adult patients with ...